Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: June 2003 July 14, 2003
With Xolair Approved, Trio Sorts Options For Peanut Allergy Drug July 7, 2003 By Randy Osborne Last month, when the FDA approved Xolair for asthma, there was much rejoicing by Genentech Inc., Tanox Inc. and Novartis Pharma AG, which developed the monoclonal antibody in a three-way deal.Read More
RSS